COVID-19 Clinical Trials Lack Diversity, Researchers Say

COVID-19 Clinical Trials Lack Diversity, Researchers Say: Although minorities are paying a disproportionate price in the rate of COVID-19 illnesses and deaths, they are underrepresented in clinical trials, a new study finds.